Hanmi accepts USD 80 million upfront payment for technology transfer from Genentech
On the 25th of January, Hanmi Pharm made a notice that the company has accepted the USD 80 million upfront payment for the 2016’s technology transfer to Genentech and separate the amount into 30 months for the accounting purpose.
Hanmi Pharm singed a technology transfer agreement of the ‘HM95573...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
